1Krzystolik M G,Afshari M A,Adamis A P,et al.Prevention of experimental choroidal neorascularization with intravitreal antivascular endothelial growth factor antibody fragment[J].Arch Ophthalmol,2002,120 (3):338-346.
2Michels S,Rosenfeld P J.Treatment of neovascular age-related macular degeneration with Ranibizumab/Lucentis[J].Klin Monatsbl Augenbeilkd,2005,222(6):480-484.
3The Eyetech Study Group.Anti-VEGF therapy for subfoveal choroidal neovascularization to age-related maculal degeneration:phase Ⅱ study results[J].Ophthalmology,2003,110:979-986.
4Moshfeghi A A,Puliafito C A.Pegaptanib sodium for the treatment of neovascular age-related macular degeneration[J].Expert Opin Investig Drugs,2005,14 (5):671-682.
5Rota R,Riccioni T,Zaccarini M,et al.Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer[J].J Gene Med,2004,6(9):992-1002.
7El Bradey M,Cheng L,Bartsch D,et al.Preventive versus treatment effect of AG3340,a potent matrix metalloproteinase inhibitor in a rat model of choroidal neovascularization[J].J Ocul Pharmacol Ther,2004,20(3):217-236.
8Penn J S.Rajaratnam V S.Inhibition of retinal neovascularization by intravitreal injection of human rPAI-1 in a rat model of retinopathy of prematurity[J].Invest Ophthalmol Vis Sci,2003,44(12):5423-5429.
9Kinose F,Roscilli G,Lamartina S,et al.Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor[J].Mol Vis,2005,11:366-373.
10Hangai M,Moon Y S,Kitaya N,et al.Systemically expressed soluble Tie 2 inhibits intraocular neovascularization[J].Hum Gene Ther,2001,12(10):1311-1321.
